vTv Therapeutics Inc.

vTv Therapeutics Inc.verified

VTVT

Price:

$14.18

Market Cap:

$45.23M

vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approac...[Read more]

Industry

Biotechnology

IPO Date

2015-07-30

Stock Exchange

NASDAQ

Ticker

VTVT

The ROE as of November 2024 (TTM) for vTv Therapeutics Inc. (VTVT) is -265.31%

According to vTv Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -265.31%. This represents a change of 1.36% compared to the average of -18.15% of the last 4 quarters.

vTv Therapeutics Inc. (VTVT) Historical ROE (quarterly & annually)

How has VTVT ROE performed in the past?

The mean historical ROE of vTv Therapeutics Inc. over the last ten years is 63.40%. The current -265.31% ROE has changed -518.45% with respect to the historical average. Over the past ten years (40 quarters), VTVT's ROE was at its highest in in the March 2022 quarter at 116.45%. The ROE was at its lowest in in the September 2024 quarter at -31.87%.

Quarterly (TTM)
Annual

Average

63.40%

Median

26.62%

Minimum

7.24%

Maximum

233.45%

vTv Therapeutics Inc. (VTVT) ROE by Quarter and Year

Discovering the peaks and valleys of vTv Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.55%

Maximum Annual ROE = 233.45%

Minimum Annual Increase = -75.38%

Minimum Annual ROE = 7.24%

Quarterly (TTM)
Annual
YearROEChange
202382.05%-64.85%
2022233.45%28.24%
2021182.04%1.55%
202011.02%-75.38%
201944.75%368.68%
20189.55%-10.66%
201710.69%-40.56%
201617.98%-49.02%
201535.27%387.29%
20147.24%-54.40%

vTv Therapeutics Inc. (VTVT) Average ROE

How has VTVT ROE performed in the past?

The current ROE of vTv Therapeutics Inc. (VTVT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

165.85%

5-year avg

110.66%

10-year avg

63.40%

vTv Therapeutics Inc. (VTVT) ROE vs. Peers

How is VTVT’s ROE compared to its peers?

vTv Therapeutics Inc.’s ROE is greater than Zura Bio Limited (-39.61%), less than Apexigen, Inc. (48.27%), greater than Phio Pharmaceuticals Corp. (-134.57%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Immix Biopharma, Inc. (-102.10%), greater than Sigilon Therapeutics, Inc. (-74.73%), greater than NovaBay Pharmaceuticals, Inc. (-1030.19%), greater than InMed Pharmaceuticals Inc. (-16230.19%), greater than GeoVax Labs, Inc. (-809.91%), greater than Generation Bio Co. (-104.85%), greater than Kronos Bio, Inc. (-64.55%), greater than Erasca, Inc. (-42.26%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Allarity Therapeutics, Inc. (-328.22%), greater than NeuroBo Pharmaceuticals, Inc. (-189.12%), greater than Hillstream BioPharma, Inc. (-172.28%), greater than Virax Biolabs Group Limited (-115.10%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Pyxis Oncology, Inc. (-36.23%), less than Altamira Therapeutics Ltd. (783.37%), greater than Elevation Oncology, Inc. (-59.73%),

Build a custom stock screener for vTv Therapeutics Inc. (VTVT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like vTv Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

vTv Therapeutics Inc. (VTVT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like vTv Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is vTv Therapeutics Inc.'s ROE?

How is the ROE calculated for vTv Therapeutics Inc. (VTVT)?

What is the highest ROE for vTv Therapeutics Inc. (VTVT)?

What is the 3-year average ROE for vTv Therapeutics Inc. (VTVT)?

What is the 5-year average ROE for vTv Therapeutics Inc. (VTVT)?

How does the current ROE for vTv Therapeutics Inc. (VTVT) compare to its historical average?